CEO Phil Lynch Talks to the Australian Shareholder Association Podcast

04 Jun
Jun , 04 , 2021 Daniel Tillett

Race CEO/MD Phillip Lynch speaks to the Australia Shareholders Association about Race Oncology and our Three Pillar strategy to commercialise Bisantrene.

LinkedIn

Related Posts